Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. ZIIHERA (zanidatamab)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ZIIHERA (zanidatamab)

Medicine - Posted on Nov 29 2024
Active substance (DCI)
  • zanidatamab
history (1)
  • 11/20/24

    ZIIHERA (zanidatamab) - Cancer des voies biliaires

    Autorisation d’accès précoce octroyée à la spécialité ZIIHERA (zanidatamab) dans l'indication « traitement des adultes attei...
    icône flèche
Technical information
ATC code
  • L01FD07
Manufacturer
Jazz Pharmaceuticals
Presentation

ZIIHERA 300 mg, poudre pour solution à diluer pour perfusion
B/1 flacon (CIP : 34009 590 058 3 0)

All our publications
    Congenital, genetic and rare diseases Digestive system cancers Drug therapy Neurodegenerative diseases Neuromuscular diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
rdT770mW5FhC4Q9n